Showing results (21-30 of 99) with videos related to

Sort By:
Pageof 10
American Journal of Human Genetics|November 8, 2016
HLA-C Level Is Regulated by a Polymorphic Oct1 Binding Site in the HLA-C Promoter RegionNicolas Vince, Hongchuan Li, Veron Ramsuran, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 9, 2023
Mechanistic model for booster doses effectiveness in healthy, cancer, and immunosuppressed patients infected with SARS-CoV-2Chrysovalantis Voutouri, C Corey Hardin, Vivek Naranbhai, et al.
Science (New York, N.Y.)|March 8, 2014
Innate immune activity conditions the effect of regulatory variants upon monocyte gene expressionBenjamin P Fairfax, Peter Humburg, Seiko Makino, et al.
Cell Reports. Medicine|March 20, 2024
In silico clinical studies for optimal COVID-19 vaccination schedules in patients with cancerChrysovalantis Voutouri, C Corey Hardin, Vivek Naranbhai, et al.
Plos One|May 31, 2024
Dynamic heterogeneity in COVID-19: Insights from a mathematical modelChrysovalantis Voutouri, C Corey Hardin, Vivek Naranbhai, et al.
BMC Infectious Diseases|July 31, 2019
Predicting the risk of pulmonary tuberculosis based on the neutrophil-to-lymphocyte ratio at TB screening in HIV-infected individualsReiko Miyahara, Surachai Piyaworawong, Vivek Naranbhai, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 14, 2013
Neither microbial translocation nor TLR responsiveness are likely explanations for preexisting immune activation in women who subsequently acquired HIV in CAPRISA 004Vivek Naranbhai, Natasha Samsunder, Netanya G Sandler, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 24, 2014
HIV disease progression in seroconvertors from the CAPRISA 004 tenofovir gel pre-exposure prophylaxis trialNigel J Garrett, Lise Werner, Nivashnee Naicker, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 25, 2012
Preservation HIV-1-specific IFNγ+ CD4+ T-cell responses in breakthrough infections after exposure to tenofovir gel in the CAPRISA 004 microbicide trialMarianne W Mureithi, Danielle Poole, Vivek Naranbhai, et al.
Pageof 10